In this study, a relatively facile porous magnetic hollow fiber engineering electrospinning method is demonstrated, which modulates fiber morphology based on secondary solvents (at variable temperatures). To demonstrate this, polycaprolactone (PCL) polymer and iron oxide nanoparticles (NPs) were used as the fibrous composite matrix. Fiber pore size increased with increasing immersed secondary solvent temperature. By contouring the surface morphology (via modulation of secondary collection solvents) of hollow magnetic fibers, drug (ketoconazole) release kinetics from spun mats were tuned. Furthermore, applying an external AC magnetic field to NP embedded porous fibers enhanced drug release. These findings are promising for altenative engineering, tuning and controlling fiber morphology and drug release behavior.
Introduction
Electrospinning (ES) is widely used to engineer continuous micro-meter and nano-meter scaled fibers from a host of materials for a variety of healthcare applications [1, 2] . Based on selected materials, process optimization (e.g. flow rate, applied voltage and working distance) and media parameters (e.g. viscosity and electrical conductivity), fibers with desirable properties are generated [2] . Coaxial ES (COES) has been used to engineer core-shell fibers with large surface to volume ratios to be effective for controlled drug release and tissue engineering [3] . However, modulation of fiber surface morphology remains limited.
Polycaprolactone (PCL) is a biocompatibile polymer, demonstrated by extensive biomateral explorations [4] .
However, PCL drug carriers exhibit slow release rates due to the hydrophilic nature of polymers [3] . In order to achieve therapeutically ideal concentrations of released active, several excipients are embedded within PCL polymer matrix [5] . Also, hollow fibers possess super specific surface areas (compared to solid fibers); permitting facilitated drug release from inner and outer faces [6] . In addtion, magnetic NPs (MNPs) are innovative functional materials which have been used to enable an enhanced release of the active ingredient [7] . However, challenges remain for the generation of hollow fibers with varied surface morphology for drug delivery applications.
In this study, a facile approach for porous magnetic hollow fiber production with fine tuned surface morphology is demonstrated. The role of secondary downstream solvent substrates (treating fibers with a second solvent (and temperature) after collecting fibers in a primary solvent) are explored as potential routes to modulate morphology and surface features. Pore formation was explored using various secondary downstream solvents (at selected temperatures). Model drug release from porous magnetic hollow fibers was studied (using ambient and externally stimulated environments).
Materials and methods

Materials
Polycaprolactone (PCL, Mw= 8x10 4 g/mol) was obtained from Sigma-Aldrich, USA. Ketoconazole (KCZ, 99.7%) was purchased from ZhongtianInstrument Chemical, China. Magnetic nanoparticles (Fe3O4, MNPs, mean size: ~20nm) were provided by HWRK Chem, China. Dichloromethane (DCM) and PBS were purchased from Sinopharm Chemical Reagent, China. Collecting solvents, including n-butanol, methanol, tetraethyl orthosilicate, 1,2-propanediol, ethanol and dimethyl silicone oil were obtained from Aladdin chemistry, China.
All chemicals were of the analytic grade. PCL (10wt.%) and KCZ (0.5wt.%) were dissolved in DCM for 2 hours using magnetic stirrer (VELP, Italy). MNPs (0.5wt.%) were added to the solution and the mixture was dispersed using bath sonication (2 hours). The final solution was used as shell material (for COES) while dimethyl silicon oil (as obtained) was the core material.
Fiber Fabrication using secondary collection solvent
An experimental COES set-up was used to produce porous magnetic hollow fibers (Fig.S1 ). The two COES media (suspension and oil) were simultaneously infused into the nozzle (inner dimethyl silicone oil=0.3ml/h and outer composite suspension=9.8ml/h) under influence of an electric field (~18 kV). Once COES stable Taylor cone was achieved, homogeneous fibers were deposited on a glass slide coated with primary collecting medium (distance=18 cm) for 15s. Immediately after deposition, fiber coated glass substrate was immersed into secondary downstream selected solvent environment (1min) to ensure interaction. In order to examine solvent temperature impact on fiber morphology, fibers were immersed in ethanol using secondary solvents at 9, 20 and 38°C. Fibers were desiccated (5days) after which dry porous magnetic hollow structures were analysed and tested further.
Characterization
Fiber morphology was assessed using optical (OM,Phenix BMC503-ICCF, China) and scanning electron microscopy (SEM,ProX, Phenom, Eindhoven, Netherlands). Fibers were analyzed using Fourier Transform infrared spectroscopy (FTIR, IR Affinity1, Shimadzu, Japan). Spectra were recorded from 400 to 4800cm -1 (resolution=4cm -1 ). Water contact angle measurements on fibrous mats were performed using an optical contact angle and interface tension meter (SL200KB, KINO Industry Ltd.,USA). Fiber diameter and pore size were measured using ImageJ software (National Institute of Health,USA). Mean diameter was obtained using 100 randomly selected fibers for each sample. The mean pore size was quantified using 40 measurements for each sample.
In vitro drug release study
Each sample analyzed for in vitro drug release comprised 30mg of fiber mats and 10mL PBS (pH=7.4) using a HZ-8801K thermostatic oscillator (TSEFactory, China) over 192hrs. Moreover, the effect of an external AC magnetic field (1.5mT) on drug release characteristics was compared to non-triggered counterpart. The characteristic UV absorbance peak of KCZ in PBS was 202nm (UV-2600 spectrophotometer, Shimadzu, Japan) [3] . KCZ release was obtained using triplicate samples. The encapsulation efficiency (EE) was obtained using Equation 1 [8] :
EE (%)=Amount of drug encapsulated in fibers/Theoretical total amount of drug×100% (1) 
Results and discussion
Porous features can be afforded through non-solvent induced phase separation [9] . Ideal experimental conditions were obtained through optimization (applied voltage:18kV, collector distance:17cm, shell/core flow rate:9.8/0.3mLh Table S1 . Fbut and Fmet possess large surface pores, which is ascribed to low viscosity of their respective solvents [9] and such porous morphology are desirable for applications in tissue engineering, which improves cell adhesion, proliferation, and cell growth [10] . In order to investigate secondary downstream collection solvent temperature effect on fiber morphology, ethanol was selected as the second medium due to its economic cost, low toxicity, safety and access to previous experimental data. The collecting temperature was set to 9, 20 and 38°C (denoted herein as F9, F20 and F38, respectively). During experimental process, all other parameters were kept constant. Fig. 2 show fiber images of F9, F20 and F38, respectively. Electron micrographs indicate increasing the solvent temperature gives rise to a topographical transition from distinctively defined (Fig. 2a' , mean pore size~2.2μm, mean fiber diameter~15.8μm) to broad shallow pores (Fig. 2c' , mean pore size~3.8μm, mean fiber diameter~15.6μm). The change in fiber pore can be explained with diffusion. As the collecting solvent temperature increases, the molecular motion of solvent becomes vigorous. Thus, the diffusion rate of solvent molecules in contact with solidifying fibers increases and a greater area of the fiber is affected (i.e. pore formation area). Varying the solvent temperature provides a facile and efficient method to refine and contour fiber morphology. 3b shows drug release data from samples prepared using ethanol collection solvent at 9, 20 and 38 °C. The cumulative release profiles from fibers deposited in ethanol solvent at all temperatures were similar to that of fiber system collected without the solvent. A typical biphasic release pattern was observed, namely a burst release followed by a slow sustained release, reaching 90% after 144 h. However, these results can be explained based on the structure of hollow porous fibers. Unlike a solid matrix filament (or tube) a hollow structure possesses a larger surface to volume ratio which enables the release of drug from two faces (inner and outer).
In addition, hollow structures demonstrate expedited drug release rates when compared to their smooth solid counterparts, due to the presence of abundant space/pores providing substantial media interaction [8] . Fig. 3c shows enhanced release from porous hollow fibers (F20) under an external AC magnetic field (AMF, 40kHz).
An external magnetic trigger (surrounding fibrous hollow mat in PBS) enhanced KCZ release, when compared to non-treated samples. The percentage of triggered KCZ release from porous magnetic fibers reached >90% after 480 min. In comparison, only ~50% of KCZ was released during the same time from non-triggered samples. This is attributed to an increase in molecular motion within the polymeric matrix via MNP responding to the trigger, which may impact PCL polymer integrity. 
Conclusions
Fiber morphology control, especially on the micron-scale, has recieved extensive attention. The contouring of electrospun fibers with incremental changes to topography remains a challenge and is essential to develop greater understanding of bio-material interfaces. In this study, an effective method to engineer magnetic hollow porous PCL fibers with control on micron scale fiber surface enhancment is demonstrated using secondary collection solvents and environments. The results indicate collecting solvent substrate type and temperature has a significant effect on the morphology of porous hollow fibers. Fibers can also be prepared with varying surface morphology, through pore tailoring, which can be designed to meet the requirements for modulated drug release and enhanced by an external AC magnetic field when required.
